Project Grant R01AR084828
Award Date
5/14/25
Completion Date
4/30/29
Dollars Obligated
$394K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Winston-Salem, NC 27109, USA
Similar Awards
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $644,152 to the University of North Carolina at Chapel Hill to conduct research into the mechanisms linking gait to the onset and progression of knee osteoarthritis (KOA). The research aims to: Determine the acute in vivo mechanistic link between sustained and dynamic limb-level...
This Project Grant award for $578,944.00, provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), supports research to decipher the genetics of osteoarthritis (OA) susceptibility, heterogeneity, and progression. The key objectives are to: 1) identify new and fine-map known genetic loci associated with susceptibility to OA and total hip/total knee arthroplasty; 2)...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $348,680 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to the University of Arizona to develop computational tools for predicting and understanding different spatial patterns of knee pain in osteoarthritis patients. The project aims to 1) adapt a deep learning approach to predict localized, regional, or diffuse knee pain from MRI data, and 2) develop an...
This federal Project Grant award of $644,887 was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award will support research conducted by the University of Rochester to investigate the role of the WNT16 protein in hip osteoarthritis progression, with a focus on understanding the genetic and epigenetic mechanisms by which mechanical loading regulates WNT16...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $174,689 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct research focused on understanding the relationship between structural damage and pain phenotypes in knee osteoarthritis. The key objectives are to investigate the links between imaging...
The federal Project Grant award of $412,610, issued by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will support research to investigate associations between the peripheral blood microbiome and knee osteoarthritis. The Oklahoma Medical Research Foundation (OMRF) will conduct this 2-year project to determine whether differences in baseline peripheral blood bacterial DNA...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $347,056 to support research on the role of vitamin K in knee osteoarthritis outcomes. The grant recipient, Trustees of Boston University, will leverage existing data from the Multicenter Osteoarthritis Study to evaluate blood thresholds of vitamin K associated with structural...
This $410,920 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) will support a research study to investigate risk factors for end-stage glenohumeral (shoulder) osteoarthritis. The key objectives are to: Determine associations between occupational exposures and risk of osteoarthritis-related shoulder arthroplasty (replacement surgery). Identify genetic...
This federal Project Grant award of $350,000 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will investigate the therapeutic potential of the NFAT1 transcription factor in treating osteoarthritis (OA). The award, effective August 1, 2024 through July 31, 2029, will support research at the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) to: 1) Evaluate the use of adeno-associated virus...
This Project Grant award of $408,669 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) supports research to identify genetic and imaging biomarkers that can predict osteoarthritis (OA) progression and joint pain. The grantee, The Regents of the University of California, San Francisco (UCSF), will leverage expertise in osteocyte biology, deep learning, and statistical...